Enhabit, Inc. (NYSE:EHAB) Stock Holdings Reduced by Cruiser Capital Advisors LLC

Cruiser Capital Advisors LLC cut its position in shares of Enhabit, Inc. (NYSE:EHAB) by 74.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,920 shares of the company’s stock after selling 69,393 shares during the period. Cruiser Capital Advisors LLC’s holdings in Enhabit were worth $187,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Fox Run Management L.L.C. raised its position in Enhabit by 290.2% during the fourth quarter. Fox Run Management L.L.C. now owns 42,237 shares of the company’s stock valued at $330,000 after acquiring an additional 31,412 shares in the last quarter. Quantbot Technologies LP bought a new position in shares of Enhabit during the 4th quarter valued at $45,000. Magnetar Financial LLC bought a new position in shares of Enhabit during the 4th quarter valued at $171,000. Intech Investment Management LLC lifted its stake in shares of Enhabit by 27.6% in the 4th quarter. Intech Investment Management LLC now owns 15,481 shares of the company’s stock valued at $121,000 after purchasing an additional 3,353 shares during the last quarter. Finally, Corient Private Wealth LLC bought a new stake in Enhabit in the fourth quarter worth $79,000.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group reaffirmed a “buy” rating on shares of Enhabit in a research report on Thursday, March 6th.

Enhabit Price Performance

Shares of Enhabit stock opened at $8.95 on Tuesday. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. The firm has a fifty day simple moving average of $8.45 and a 200-day simple moving average of $7.96. The stock has a market capitalization of $451.70 million, a price-to-earnings ratio of -3.86 and a beta of 1.80. Enhabit, Inc. has a 1-year low of $6.85 and a 1-year high of $11.74.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.